SW, O., BM, G., A, B., & PM, M. (2025). Combined treatment with antitoxin and 3,4-diaminopyridine improves survival outcomes after lethal botulinum neurotoxin challenge. Molecular medicine (Cambridge, Mass.), 31(1), 270. https://doi.org/10.1186/s10020-025-01316-0
Chicago Style (17th ed.) CitationSW, O'Brien, Gregg BM, Bollapragada A, and McNutt PM. "Combined Treatment with Antitoxin and 3,4-diaminopyridine Improves Survival Outcomes After Lethal Botulinum Neurotoxin Challenge." Molecular Medicine (Cambridge, Mass.) 31, no. 1 (2025): 270. https://doi.org/10.1186/s10020-025-01316-0.
MLA (9th ed.) CitationSW, O'Brien, et al. "Combined Treatment with Antitoxin and 3,4-diaminopyridine Improves Survival Outcomes After Lethal Botulinum Neurotoxin Challenge." Molecular Medicine (Cambridge, Mass.), vol. 31, no. 1, 2025, p. 270, https://doi.org/10.1186/s10020-025-01316-0.